Clinical characteristics of patients with SLE by year of presentation
| Previous year period (18 March 2019 to 9 June 2019) | COVID-19 period (18 March 2020 to 9 June 2020) | |
| Age (years), mean±SD | 34±15 | 38±11 |
| Female, n (%) | 30 (88) | 16 (89) |
| Total admission | 52 | 18 |
| Total patients | 34 | 18 |
| New case | 2 | 6 |
| Death | 0 | 3 |
| Length of stay, mean±SD | 8.81±11 | 8.39±6 |
| ICU stay | 2 | 4 |
| Clinical presentation | ||
| Flare | 20 (38.5%) | 7 (38.9%) |
| Flare and infection | 6 (11.5%) | 3 (16.7%) |
| Infection | 11 (21.2%) | 4 (22.2%) |
| Others | 15 (28.8%) | 4 (22.2%) |
| Renal biopsy, n (%) | 7 (13.5%) | 0 |
| Haemodialysis training, n (%) | 9 (17.3) | 0 |
| Type of flare, n | ||
| Renal | 21 | 3 |
| Mucocutaneous | 10 | 8 |
| Haematological | 5 | 9 |
| Serositis | 1 | 4 |
| Arthritis | 0 | 2 |
| Neurological | 1 | 0 |
| SLEDAI, mean±SD | 10±5.6 | 13±8.9 |
ICU, intensive care unit; SLE, systemic lupus erythematosus; SLEDAI, Systemic Lupus Erythematosus Disease Activity Index.